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Abstract 
Background: Delayed reconstruction of transection or laceration injuries of peripheral nerves is inflicted by a 
reduced regeneration capacity. Diabetic conditions, more frequently encountered in clinical practice, are known to 
further impair regeneration in peripheral nerves. Chitosan nerve guides (CNGs) have recently been introduced as a 
new generation of medical devices for immediate peripheral nerve reconstruction. Here, CNGs were used for 45 days 
delayed reconstruction of critical length 15 mm rat sciatic nerve defects in either healthy Wistar rats or diabetic 
Goto‑Kakizaki rats; the latter resembling type 2 diabetes. In short and long‑term investigations, we comprehensively 
analyzed the performance of one‑chambered hollow CNGs (hCNGs) and two‑chambered CNGs (CFeCNGs) in which a 
chitosan film has been longitudinally introduced. Additionally, we investigated in vitro the immunomodulatory effect 
provided by the chitosan film.
Results: Both types of nerve guides, i.e. hCNGs and CFeCNGs, enabled moderate morphological and functional 
nerve regeneration after reconstruction that was delayed for 45 days. These positive findings were detectable in 
generally healthy as well as in diabetic Goto‑Kakizaki rats (for the latter only in short‑term studies). The regenerative 
outcome did not reach the degree as recently demonstrated after immediate reconstruction using hCNGs and  
CFeCNGs. CFeCNG‑treatment, however, enabled tissue regrowth in all animals (hCNGs: only in 80% of animals). 
CFeCNGs did further support with an increased vascularization of the regenerated tissue and an enhanced regrowth 
of motor axons. One mechanism by which the CFeCNGs potentially support successful regeneration is an immu‑
nomodulatory effect induced by the chitosan film itself. Our in vitro results suggest that the pro‑regenerative effect of 
chitosan is related to the differentiation of chitosan‑adherent monocytes into pro‑healing M2 macrophages.
Conclusions: No considerable differences appear for the delayed nerve regeneration process related to healthy and 
diabetic conditions. Currently available chitosan nerve grafts do not support delayed nerve regeneration to the same 
extent as they do after immediate nerve reconstruction. The immunomodulatory characteristics of the biomaterial 
may, however, be crucial for their regeneration supportive effects.
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Background
Transection or laceration injuries of peripheral nerves 
regularly need microsurgical reconstruction. This should 
be performed as early as possible, e.g. immediately after 
the trauma or within a few days [1]. Under certain cir-
cumstances, however, a delay of nerve reconstruction for 
up to several weeks is advisable. This can be the case after 
a motor-cycle accident resulting in brachial plexus lesions 
together with multiple other injuries, or after gun-shot 
or shrapnel widespread injuries where all injured tissue 
should have healed properly before nerve reconstruction 
and when the risk for infection is low [1]. The delay of 
microsurgical nerve reconstruction is, however, known 
for several reasons to result in worse axonal regenera-
tion and a poor clinical outcome. Severe peripheral nerve 
lesions result in eventually life-long paralysis, severely 
impaired sensation, reduced functionality and/or pain 
[2]. The gold standard therapy for tension-free recon-
necting nerve ends [3] is the use of autologous nerve 
grafts. Harvesting the nerve grafts is, however, accompa-
nied by the need of a secondary surgery and loss of donor 
nerve function [4, 5]. Autologous nerve tissue addition-
ally has a limited availability and brachial plexus lesions 
for example often need a considerably high amount of 
graft material. Therefore, alternatives to autologous nerve 
grafts are highly warranted [6].
Recently, we contributed to the development of a new 
generation of hollow chitosan nerve guides providing 
appropriate support of the regenerating rat sciatic nerve 
after reconstruction of 10–15 mm peripheral nerve gaps 
[7–9]. We additionally demonstrated that the degree of 
functional recovery after immediate reconstruction of 
15  mm rat sciatic nerve gaps can even be increased by 
longitudinally introducing a perforated chitosan film into 
the hollow nerve guides as guidance structure for out-
growing axons [10].
The first objective of the current study relates to the 
growing incidence of a systemic diseases inflicting dam-
age to the peripheral nervous system, i.e. diabetes. The 
global number of patients with type 1 and 2 diabetes will 
grow substantially in the coming decades. This is due 
to a real increase in incidence of type 1 diabetes as well 
as caused by an older population globally and thereby 
increasing the number of patients with type 2 diabe-
tes, where the incidence is stable. Therefore, any type of 
new medical device should be tested in diabetic condi-
tions; an aspect which is not often highlighted in the lit-
erature. This is of specific importance also for new nerve 
guides. Recently, we showed in short-term investigations 
in diabetic Goto-Kakizaki (GK) rats, with moderately 
increased and clinically relevant blood glucose levels, suf-
ficient nerve regeneration through chitosan nerve guides 
and autologous nerve grafts bridging short and criti-
cal length sciatic nerve defects of up to 15 mm [10, 11]. 
Consequently, our first objective in the current study was 
to evaluate if sufficient nerve regeneration could also be 
observed in short-term evaluation in healthy Wistar and 
in diabetic GK rats after a delayed nerve reconstruction 
bridging the longer nerve defect (15  mm) with two dif-
ferent types of chitosan nerve guides that earlier have 
demonstrated their beneficial effect after acute nerve 
reconstruction [10]. Therefore, reconstruction of 15 mm 
rat sciatic nerve gaps has been delayed for 45  days. 
Reconstruction was performed using one-chambered 
hollow chitosan nerve guides (hCNGs) or two-cham-
bered chitosan film enhanced chitosan nerve guides 
(CFeCNGs).
After general tissue regeneration, functional recovery 
after severe peripheral nerve injury and subsequent sur-
gical reconstruction is highly important. Consequently, 
the second objective of the current study was to evalu-
ate in long-term experiments if our chitosan nerve guides 
support functional recovery also after the surgical nerve 
reconstruction has been substantially delayed.
Finally, to make our conclusions round, we elucidated 
a potential mechanism by which the chitosan mate-
rial used for our nerve guides could specifically support 
peripheral nerve regeneration. In the context of nerve 
graft reconstruction, an immunomodulatory effect on 
the polarization of invading macrophages towards a pro-
healing phenotype has been described important for 
sufficient tissue regrowth and axonal regeneration [12]. 
Chitosan materials have demonstrated to induce simi-
lar immunomodulation, at least when implanted subcu-
taneously [13]. To prove that our chitosan material has 
indeed immunomodulatory and pro-healing properties 
for macrophages invading the nerve guides, we provide 
novel results from an in vitro evaluation of blood-derived 
human monocyte polarization with contact to our chi-
tosan material.
Results
Experimental design
To induce a delayed nerve reconstruction scenario, the 
left sciatic nerve of each animal has been initially tran-
sected and spontaneous regeneration has been prevented 
by loop-like suturing the nerve ends to themselves as 
illustrated in Additional file 1: Figure S1.
Keywords: Chitosan nerve guide, Delayed nerve reconstruction, Diabetes, Regenerative matrix, Immunomodulation
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After 45  days, the nerve reconstruction surgery was 
performed using either hCNGs or CFeCNGs to bridge 
a 15  mm rat sciatic nerve gap. Although grafting with 
autologous nerve tissue is the gold standard therapy in 
the clinical treatment of severe peripheral nerve inju-
ries, this reconstruction approach could not be used as 
control here. At 45 days after injury, the nerve ends have 
considerably been pulling away from each other dur-
ing the delay phase. This resulted in an unavailability of 
enough ipsilateral autologous sciatic nerve material to be 
used as the commonly applied reversed autograft known 
from immediate reconstruction studies [7, 10]. Since we 
had no ethical permission to harvest autologous nerve 
tissue from the contralateral side, which would also have 
inflicted the functional evaluation, and the use of addi-
tional donor animals was determined an inappropriate 
increase of animals to be used in this study, we focused 
this study on the evaluation of putative differences in the 
performances of CFeCNGs compared to hCNGs that 
are already clinically used. Table 1 provides an overview 
of the two parallel studies and the respective read-outs 
performed.
Study I (56  days short-term observation) was con-
ducted in generally healthy or diabetic Goto-Kakizaki 
(GK) rats [14] and evaluated the following groups: 
hCNG-Ihealthy, hCNG-Idiabetic, CFeCNG-Ihealthy, and 
CFeCNG-Idiabetic (Table  1). With immunohistological 
techniques, the formed regenerative matrix (if formed) 
and distal nerve segment (axonal outgrowth, Schwann 
cell activation and apoptosis) as well as the activation and 
neuroprotection of sensory dorsal root ganglion (DRG) 
neurons were analyzed [10].
Study II (150  days long-term observation) included 
the following groups: hCNG-II and CFeCNG-II. A mis-
match in animal numbers in study I and II was created 
by the fact that some animals had to be excluded from 
the study before actual nerve reconstruction due to signs 
of automutilation. Functional recovery was periodi-
cally assessed and completed by endpoint histology and 
morphometrical analysis of axonal regeneration; the lat-
ter was executed at the Geuna lab at University of Turin 
(UNITO, Italy).
Short‑term evaluation of the regenerative matrix 
and dorsal root ganglia at 56 days after delayed nerve 
reconstruction (study I)
Preoperative blood glucose levels differed between the 
healthy Wistar rats and the diabetic GK rats (Table  2), 
but did not differ between the rats from the hCNG or 
CFeCNG groups. The blood glucose values in the corre-
sponding groups did not differ pre- and postoperatively 
(results not shown).
In the following, we describe the results of multi-
ple immunohistological analyses. For all stainings per-
formed, control procedures with omitting primary or 
secondary antibodies were performed and resulted in 
unstained sections (not presented).
The described procedures have been performed in dif-
ferent previous studies and are routine procedures to 
analyze the regenerating conditions short-term after 
peripheral nerve reconstruction with tubular grafts [7, 
10, 11, 14].
Regenerative matrix
The formation of a regenerative matrix is a prerequi-
site for successful regeneration of a peripheral nerve 
through a tubular graft [15]. A complete regenerative 
matrix, i.e. extending and completely connecting the 
proximal and distal nerve ends, was not detected mac-
roscopically in all conduits. A complete single-strand 
matrix was observed in 4/5 hCNG-Ihealthy rats, while 
a complete single-strand was only observed in 3/11 
hCNG-Idiabetic rats. No complete separate strands were 
detected in the other rats of these two groups. In the six 
Table 1 Overview of the experimental design of the two parallel sub-studies
GK Goto-Kakizaki rats, hCNG hollow chitosan nerve guides, CFeCNG chitosan film enhanced chitosan nerve guides, I short-term experiments, II long-term experiments, 
ULUND University of Lund, MHH Medizinische Hochschule Hannover, i.e. Hannover Medical School
Study Observation 
time (days)
Experimental groups n Group name Performed experiments
Study I (ULUND) 56 Healthy rats: Hollow chitosan nerve guide 5 hCNG‑Ihealthy Analysis of regenerative matrix and distal 
nerve segment: Presence of axons and 
activated and apoptotic Schwann cells 
by immunohistology; Analysis of sen‑
sory dorsal root ganglion activation and 
neuroprotection by immunohistology
Diabetic GK rats: Hollow chitosan nerve guide 11 hCNG‑Idiabetic
Healthy rats: Chitosan film enhanced chitosan 
nerve guide
6 CFeCNG‑Ihealthy
Diabetic GK rats: Chitosan film enhanced 
chitosan nerve guide
7 CFeCNG‑Idiabetic
Study II (MHH) 150 Hollow chitosan nerve guide 10 hCNG‑II Motor recovery: Non‑invasive electro‑
physiology (60, 90, 120, 150 days) and 
muscle weight ratio; Histomorphom‑
etry; Immunohistology
Chitosan film enhanced chitosan nerve guide 7 CFeCNG‑II
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CFeCNG-Ihealthy rats, a complete single-strand matrix 
was observed in two rats and a complete double-strand 
matrix in another two rats. In contrast, a complete dou-
ble-strand matrix was observed in 6/7 CFeCNG-Idiabetic 
rats and a complete single-strand in the last CFeCNG-
Idiabetic rat (Table 2).
The regenerative matrices were relatively thin and 
therefore not all of immunohistological procedures 
described in the following could be performed in all of 
them.
Axonal outgrowth
Within the distal nerve segment, the presence of axons 
immunopositive for neurofilament indicates that regen-
erating axons have crossed the regenerative matrices 
within the nerve guides. Positive neurofilament staining 
was detected in the distal nerve segment in all the rats 
in all groups without any obvious differences between 
the groups (Table  2). The regenerative matrices within 
the conduits were extremely thin and therefore not 
additionally analyzed for the presence of neurofilament 
immunoreactivity.
Priority was given to analyses of activated and apop-
totic Schwann cells in the formed matrices as described 
in the following.
Activated Schwann cells
Activated Schwann cells, defined as ATF-3 stained 
Schwann cells [10, 11, 14], were observed in the formed 
regenerative matrix in generally small proportions 
(median values 6.0–16.8%). The values displayed no 
significant differences between the groups (Table  2; it 
should be recognized that only few matrices were avail-
able for immunostaining in the middle of the conduit, 
particularly in the hCNG-Ihealthy samples). Furthermore, 
the proportion of ATF-3 stained Schwann cells in the dis-
tal nerve segment (Fig. 1A–D) did not significantly differ 
(median values 6.5–12.2%, Table 2). No differences were 
found between healthy and diabetic GK rats. Double-
staining of ATF-3 and S-100 (Additional file  2: Figure 
Table 2 Nerve regeneration in healthy Wistar rats and in diabetic Goto-Kakizaki (GK) rats
At 45 days post injury, a 15 mm long sciatic nerve defect has been bridged by a one-chambered hollow chitosan nerve guide (hCNG-I) or a two-chambered chitosan 
nerve guide with a centrally introduced chitosan film (CFeCNG-I). Evaluation was performed after a further 56 days. Values are median 25th(Q1)–75th(Q3) percentiles
Italic p-values indicate statistically significant differences (p < 0.05) between the examined groups
KW Kruskal–Wallis, SND distal nerve segment, TFO too few observations to apply statistics, NA not applicable (i.e. KW = Kruskal–Wallis not significant)
a Fisher’s method for independent samples based on the Chi square distribution from the subsequent Mann–Whitney test after Kruskal–Wallis test
b 6 missing values
c 7 missing values
d 2 missing values
hCNG‑Ihealthy 
(n = 5)
CFeCNG‑Ihealthy 
(n = 6)
hCNG‑Idiabetic 
(n = 11)
CFeCNG‑Idiabetic 
(n = 7)
p‑values 
(KW)
Fisher’s  methoda
hCNG‑I/
CFeCNG‑I
Healthy/
diabetic
Preoperative B‑glucose 
(mmol/l)
3.9 [3.7–4.3] 4.0 [3.4–4.1] 7.9 [7.1–8.7] 8.1 [6.7–8.6] 0.0001 0.96 <0.0001
Regenerative Matrix 
Present (non‑complete/
complete single‑strand/
complete double‑strand)
1/4/0 2/2/2 8/3/0 0/1/6 NA NA NA
Axonal outgrowth (neuro‑
filament present in SND)
5/5 6/6 11/11 7/7 NA NA NA
ATF‑3 (% of total)
 At 3 mm 8.1 [3.0–9.1] 8.8 [6.2–10.6] 6.0 [4.5–10.4] 9.5 [5.2–11.1] 0.51 NA NA
 In conduit TFO 11.4 [6.8–12.7]d 16.8 [15.8–22.3]b 14.2 [10.3–22.5] 0.29 NA NA
 In SND 7.3 [6.2–16.7] 10.2 [8.6–12.9] 12.2 [9.4–14.3] 6.5 [6.0–11.1] 0.23 NA NA
Cleaved caspase‑3 (% of total)
 At 3 mm 30.5 [27.4–37.7] 31.2 [25.2–33.1] 31.9 [28.8–46.8] 19.1 [14.6–20.1] 0.004 0.001 0.02
 In conduit TFO TFO 14.2 [12.5–16.1]c 12.9 [11.1–17.6] 0.082 NA NA
 In SND 28.0 [22.1–33.5] 28.6 [25.2–38.8] 37.8 [27.1–41.7] 37.4 [30.7–39.2] 0.36 NA NA
DAPI stained cells (no/mm2)
 At 3 mm 167 [139–195] 156 [129–185] 184 [152–206] 169 [151–232] 0.59 NA NA
 In conduit TFO 3490 [3362–3980]d 1727 [1412–2921] 3198 [1991–3635] 0.21 NA NA
 In SND 2823 [2201–3234] 2542 [2083–3036] 3071 [2445–3454] 2732 [2330–3733] 0.60 NA NA
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S2A–D) was done to show that the ATF-3 staining was 
located in the oval cell nuclei of S-100 immunopositive 
Schwann cells in accordance with previous studies [11].
Apoptotic Schwann cells
Staining for cleaved caspase-3 was used to detect apop-
totic Schwann cells in the regenerative matrix and in 
the distal nerve segment [10, 11, 14]. The proportions of 
cleaved caspase-3 immunopositive Schwann cells differed 
between the groups at 3 mm distal to the proximal suture 
in the formed matrices, where the Fisher test indicated a 
lower percentage in the diabetic GK rats versus healthy 
Wistar rats and in the CFeCNG-I samples versus hCNG-
I samples (Table  2). No statistical differences, based on 
the possibility to apply statistics, were observed in the 
middle of the conduit (but again, it should be recognized 
that only few matrices were available for immunostaining 
in the middle of the conduit, particularly in the hCNG-
Ihealthy samples and that the results should be interpreted 
with caution) or in the distal nerve segment (Fig. 1E–H). 
Again, no differences were found between healthy Wistar 
rats and diabetic GK rats. Double-staining of cleaved 
caspase-3 and S-100 was done to show that the cleaved 
caspase-3 staining was located in the oval cell nuclei of 
S-100 immunopositive Schwann cells in accordance with 
previous studies (Additional file 2: Figure S2E–H, [10]).
Total number of cells
Nuclei of all cells were counterstained with DAPI in 
order to define the percentage of activated or apoptotic 
Schwann cells in the analyzed areas. There were no sig-
nificant differences between the groups concerning the 
total number of DAPI stained cells in the matrix at 3 mm 
from the proximal suture, in the matrix in the middle of 
the conduit and in the distal nerve segment (Table  2). 
However, only few matrices were possible to evaluate in 
the hCNG-Ihealthy rats and statistics could not be applied 
to that group.
Dorsal root ganglia
Sensory dorsal root ganglia located at the lumbar level 
(L3-L5) should regenerate their peripheral axons into 
the reconstructed nerve for recovery of e.g. nocicep-
tion, mechanosensitivity and proprioception. In order to 
do so, they need to be protected from axotomy-induced 
cell death. Evaluation of ATF-3 and HSP-27 immunore-
activity of the corresponding dorsal root sensory neu-
rons revealed their regeneration state and the results are 
described in the following.
Activated sensory neurons
Activated sensory neurons, i.e. ATF-3 stained neurons 
(Fig. 2), were evaluated in the sensory neurons in DRGs 
according to a previously published method [10]. No dif-
ferences were found on the control side, which revealed 
significantly smaller proportions of ATF-3 immunopo-
sitive neurons than on the experimental side (Table  3). 
On the experimental side, generally a small proportion 
of ATF-3 stained sensory neurons were detected (5.0–
5.7%). Significantly bigger proportions, however, were 
observed in the DRGs from CFeCNG-I healthy or dia-
betic rats when compared to DRGs from hCNG-I healthy 
or diabetic rats (Table 3). No statistical differences were 
found between healthy and diabetic rats.
Area of HSP‑27 stained sensory neurons
The expression of the neuroprotective protein HSP-
27 was evaluated in sensory neurons (Fig.  3) in DRGs 
according to a previously described method, being differ-
ent from the assessment of ATF-3 stained sensory neu-
rons (see above) [10]. On the control side, the HSP-27 
expressing area in the sections from DRGs was 6.6–9.9% 
of the complete area of the section with no difference 
between the groups (Table 3). On the contralateral exper-
imental side, 16.4–18.2% of the DRG areas were HSP-
27 immunopositive, again with no differences between 
the groups. However, if a ratio between the HSP-27 
expressed area on the experimental and control sides was 
calculated [10], a statistical difference was observed with 
higher values in the diabetic GK rats (Table 3), indicating 
a higher degree of neuroprotective mechanisms acting in 
diabetes after the present nerve injury and reconstruc-
tion. Interestingly, higher HSP-27 levels in serum are 
generally associated with better nerve function in both 
healthy subjects and in patients with type 2 diabetes 
although lower levels are found in type 2 patients [16].
Correlations for all rats examined
Relevant correlations were also analyzed when the results 
from all rats were pooled together, but not in individual 
(See figure on next page.) 
Fig. 1 Distal nerve segments 56 days after delayed nerve reconstruction stained for ATF‑3 and cleaved caspase‑3. A–D Photomicrographs present 
immunohistology for ATF‑3. E–H Photomicrographs present immunohistology for cleaved caspase‑3. Inserts are magnifications from the image 
showing the oval ATF‑3 (rabbit anti‑ATF‑3 polyclonal antibody) and cleaved caspase‑3 (anti‑cleaved caspase‑3 antibody) stained cells interpreted as 
Schwann cells (secondary antibody Alexa Fluor 488 conjugated goat anti‑rabbit IgG; green; see methods and Additional file 2: Figure 2). hCNG-Ihealthy 
hollow chitosan nerve guide from healthy rats, CFeCNG-Ihealthy chitosan film enhanced chitosan nerve guide from healthy rats, hCNG-Idiabetic hollow 
chitosan nerve guide from diabetic GK rats, CFeCNG-Idiabetic chitosan film enhanced chitosan nerve guide from diabetic rats. For details of the results 
of the quantification see Table 2. Scale bars display 100 µm in all images
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groups due to at times only few observations in each 
group. The preoperative blood glucose values correlated 
with the proportions of cleaved caspase-3 immunopo-
sitive Schwann cells (hCNG-I and CFeCNG-I pooled) 
in the distal nerve segment (r  =  0.426, p  =  0.02). The 
preoperative blood glucose levels also correlated nega-
tively with the HSP-27 on the control side (r  =  −0.55, 
p = 0.003), but positively with the HSP-27 ratio (r = 0.50, 
p = 0.008).
The proportions of cleaved caspase-3 immunoposi-
tive apoptotic Schwann cells in the regenerative matrix 
at 3 mm from the proximal suture correlated negatively 
with the proportions of ATF-3 stained sensory neurons 
in DRGs on the experimental side (r = −0.41, p = 0.034). 
The proportions of cleaved caspase-3 immunopositive 
apoptotic Schwann cells in the distal nerve segment cor-
related negatively with the HSP-27 immunopositive area 
on the control side (r = −0.42, p = 0.03).
The HSP-27 ratio positively correlated with the HSP-27 
immunopositive area on the experimental side (r = 0.51, 
p = 0.007). Furthermore, the HSP-27 ratio also correlated 
negatively with the HSP-27 expressing area on the con-
trol side (r = −0.59, p = 0.001).
Assessment of functional motor recovery over a period 
of 150 days after delayed nerve reconstruction (study II)
The first measure to detect successful reinnervation of 
motor targets after delayed reconstruction of a 15  mm 
sciatic nerve gap in rats was electrodiagnostic recording 
of evoked compound muscle action potentials (CMAPs) 
from a more proximal lower limb target muscle (ante-
rior tibial muscle) and the plantar interosseous muscles 
located more distal in the paw of the animals. Table  4 
summarizes the timeline of the reinnervation processes 
as determined in periodic measurements.
Analyzing the qualitative parameter of functional 
muscle reinnervation (yes or no), a positive response 
was detectable earlier in the hCNG-II group than in 
the CFeCNG-II group. At 60 and 90  days post-surgery, 
regenerating axons in the CFeCNG-II group displayed a 
Table 3 Immunohistology for  activated and  neuroprotected sensory neurons in  healthy and  diabetic rats after  nerve 
reconstruction
Activation was detected by ATF-3 immunostaining and neuroprotection by HSP-27 immunostaining in dorsal root ganglion sensory neurons at 56 days after delayed 
nerve reconstruction in healthy Wistar rats and diabetic Goto-Kakizaki (GK) rats. At 45 days post injury a 15 mm long sciatic nerve defect was bridged by a hollow 
chitosan nerve guide (hCNG-I) or a chitosan nerve guide with a centrally introduced chitosan film (CFeCNG-I)
Values are median (interquartile range; IQR)
Italic p-values indicate statistically significant differences (p < 0.05) between the examined groups
NA = not applicable (i.e. KW = Kruskal–Wallis not significant)
a KW = Kruskal–Wallis
b Fisher’s method for independent samples based on the Chi square distribution
c–j Wilcoxon = statistical difference between experimental and control sides; c 0.043; d 0.005; e 0.043; f 0.018; g 0.043; h 0.005; i 0.043; j 0.018; respectively
k One missing value in the group
Treatment Immunohistology of dorsal root ganglia (DRG; L4/L5)
ATF‑3 control (% 
of total sensory 
neurons)
ATF‑3 experimental 
(% of total sensory 
neurons)
HSP‑27 control (% 
of area in sections 
of DRG)
HSP‑27 experimental 
(% of area in sections 
of DRG)
HSP‑27 ratio Exp/Con
hCNG‑Ihealthy (n = 5) 1.4 [1.0–2.9] 3.1 [2.9–4.0]c 9.9 [7.6–10.1] 16.5 [15.6–18.5]g 1.9 [1.7–2.1]
hCNG‑Idiabetic (n = 11)k 1.8 [1.1–2.6] 4.6 [3.7–4.9]d 6.6 [6.0–6.9] 17.1 [15.3–19.8]h 2.6 [2.4–3.0]
CFeCNG‑Ihealthy (n = 6)k 1.5 [1.2–1.8] 5.0 [4.9–6.1]e 8.2 [6.5–10.6] 16.4 [11.0–23.5]i 1.7 [1.5–2.7]
CFeCNG‑Idiabetic (n = 7) 2.3 [1.2–2.6] 5.7 [5.0–6.0]f 8.3 [5.4–9.1] 18.2 [14.9–19.0]j 2.2 [2.1–2.8]
p‑valuea (KW) 0.77 0.001 0.06 0.84 0.034
Fisher’s  methodb
 hCNG‑I/CFeCNG‑I NA 0.0001 NA NA 0.36
 Healthy/diabetic NA 0.14 NA NA 0.004
(See figure on previous page.) 
Fig. 2 Dorsal root ganglia at 56 days after delayed nerve reconstruction stained for ATF‑3. Photomicrographs present ATF‑3 stained sensory dorsal 
root ganglion neurons (green) from the uninjured control side (Con, left column; A, C, E, G) and the experimental side (Exp, right column; B, D, F, H). 
hCNG-Ihealthy hollow chitosan nerve guide from healthy rats, CFeCNG-Ihealthy chitosan film enhanced chitosan nerve guide from healthy rats, hCNG-
Idiabetic hollow chitosan nerve guide from diabetic GK rats; CFeCNG-Idiabetic chitosan film enhanced chitosan nerve guide from diabetic rats. For details 
of the results of the quantification see Table 3. Scale bars display 200 µm in all images (scale bars represent different lengths due to different sizes of 
the DRG sections)
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lower proportion of reinnervated tibialis anterior mus-
cles, while a considerable higher percentage (10 and 40%, 
respectively) of animals in the hCNG-II group demon-
strated reinnervation of these lower limb muscles. From 
120  days after surgery onwards, the CFeCNG-II group 
caught up and demonstrated a comparable percentage 
of reinnervated tibialis anterior muscles (43 vs. 50% in 
hCNG-II group) with even surpassing the percentage in 
the hCNG-II group (stabilized 50% vs. further elevated 
71% in CFeCNG-II group) at day 150. Reinnervation 
of the plantar interosseous muscle, however, did occur 
exclusively in a single animal of the hCNG-II and was 
detectable from 120 days post-surgery onward.
Quantitative parameters, like the CMAP amplitude 
ratios and the nerve conduction velocities ratios recorded 
from the tibialis anterior muscles, were additionally ana-
lyzed and are depicted in Additional file 3: Figure 3A and 
B. It is clearly visible from the dot plots that among the 
animals that displayed electrodiagnostically detectable 
reinnervation, no significant difference occurred between 
the two groups. The muscle weight ratio (Additional 
file 3: Figure S3C) was calculated as a second measure to 
quantify the extent of muscle reinnervation that was in 
accordance with the previous result.
Macroscopic inspection at the time of explantation 
(150 days after delayed nerve reconstruction)
Just before tissue harvest for histological processing, a 
careful macroscopic observation of the reconstructed 
nerves in study II at 150  days after the delayed recon-
struction surgery was performed. As summarized in 
Table  5, we detected a discrepancy between the visible 
tissue regeneration and the electrodiagnostically detect-
able functionality of the nerves.
While in two animals of the hCNG-II group a complete 
failure of regeneration occurred, we detected in 3/10 
animals a tissue bridge between the former nerve ends 
additionally to the tissue bridges found in 5/10 animals 
Table 4 Timing for recovery of evocable CMAPs
The table gives a timeline of functional motor recovery detected as evocable CMAPs recorded from the tibialis anterior or plantar muscles upon transcutaneous 
stimulation of the reconstructed sciatic nerve. * Indicates a significant difference (p < 0.05) between hCNG-II and CFeCNG-II at the same time point and for the same 
muscle as determined in the Chi square test
Muscle Nerve guide 60 days 90 days 120 days 150 days
Animals/group [%] Animals/group [%] Animals/group [%] Animals/group [%]
Tibialis anterior hCNG‑II 1/10 10* 4/10 40 5/10 50 5/10 50
CFeCNG‑II 0/7 0 1/7 14 3/7 43 5/7 71*
Plantar interosseus hCNG‑II 0/10 0 0/10 0 1/10 10* 1/10 10*
CFeCNG‑II 0/7 0 0/7 0 0/7 0 0/7 0
Table 5 Correlation of electrodiagnostically detectable motor recovery with macroscopic tissue regeneration
The table illustrates the relationship between electrodiagnostically detectable reinnervation of the tibialis anterior muscles and the visibility of a regenerated 
tissue bridge between the previous nerve ends within the nerve guides. In both groups, more tissue bridges have been regenerated than axonal outgrowth had 
already established reinnervation of the evaluated target muscles at 150 days after delayed nerve reconstruction. In the hCNG-II, however, also a complete failure of 
regeneration occurred in 2 animals. * Indicates a significant difference (p < 0.05) between hCNG-II and CFeCNG-II (Chi square test)
Nerve guide n Evocable CMAPs  
(tibialis anterior muscle)
Regenerated tissue  
without evocable CMAP
No regenerated tissue
Animals/group [%] Animals/group [%] Animals/group [%]
hCNG‑II 10 5 50 3 30 2 20
CFeCNG‑II 7 5 71* 2 29 0 0*
(See figure on previous page.) 
Fig. 3 Dorsal root ganglia at 56 days after delayed nerve reconstruction stained for HSP‑27. Photomicrographs present HSP‑27 stained sensory 
dorsal root ganglion neurons (green) from the uninjured control side (Con, left column; A, C, E, G) and the experimental side (Exp, right column; B, 
D, F, H). hCNG-Ihealthy hollow chitosan nerve guide from healthy rats, CFeCNG-Ihealthy chitosan film enhanced chitosan nerve guide from healthy rats, 
hCNG-Idiabetic hollow chitosan nerve guide from diabetic GK rats, CFeCNG-Idiabetic chitosan film enhanced chitosan nerve guide from diabetic rats. For 
details of the results of the quantification see Table 3. Scale bars display 200 µm in all images (bars represent different lengths due to different sizes 
of the DRG sections)
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with evocable CMAPs within the tibialis anterior muscle 
upon transcutaneous sciatic nerve stimulation directly 
proximal and distal to the nerve guide. In the CFeCNG-II 
group a more favorable balance was detected as all ani-
mals demonstrated tissue bridges connecting the former 
nerve ends within the nerve guides and the percentage of 
animals without detectable CMAPs was similar to that in 
the other group.
With the help of a surgical microscope it was possi-
ble to visualize that in one-chambered hollow hCNGs 
the regenerated tissue bridges were single-stranded, 
whereas in the two-chambered CFeCNGs they appeared 
double-stranded. As illustrated in Fig. 4, the latter were 
connected to each other by small tissue bridges grown 
through the holes within the central chitosan films. Addi-
tionally, these connections eventually contained small 
vessels resulting in a visually increased vascularization of 
the regenerated tissue within the CFeCNGs.
Histomorphometrical evaluation at 150 days after delayed 
nerve reconstruction (study II)
Nerve histochemistry and immunohistology
Additionally to the macroscopic inspection, we per-
formed histology of the regenerated tissue in order to 
demonstrate the different organization of the regrow-
ing axons within the different types of nerve guides. As 
shown in Fig. 5 cross-sections through the distal part of 
the regenerated tissue within the nerve guides revealed 
the single-stranded morphology of it within the hCNG-
II nerve guides and the double-stranded one within the 
CFeCNG-II nerve guides. The double-stranded regener-
ates were commonly divided in one strand of bigger and 
one strand of smaller diameter, both containing regener-
ating axons in close vicinity to the chitosan film (Fig. 5). 
The trichrome staining further visualized that within the 
CFeCNG-II nerve guides a larger amount of connective 
tissue was formed, but that it did not contain any con-
siderable amount of fibrotic collagen fibers which would 
have been demonstrated in clear green color (Fig. 5).
Sections consecutive to those processed in trichrome 
staining were incubated with antibodies against the 
general axonal marker neurofilament 200 (NF200) and 
the marker for motor axons choline acetyl transferase 
(ChAT) to indicate the areas of axonal regeneration 
(Fig.  6A, B). Double-staining against NF200 and ChAT 
was further used to quantify the number of immuno-
positive axons (Fig.  6C) and to calculate the percentage 
of ChAT-immunopositive axons among all regenerated 
NF200-immunopositive axons (Fig.  6D). The percent-
age of regenerated motor axons (ChAT-immunopositive) 
was significantly increased in CFeCNG-II regenerates in 
comparison to hCNG-II regenerates.
Fig. 4 Presentation of the macroscopic appearance of the regenerated tissue upon explantation. At 150 days after delayed nerve reconstruc‑
tion, the implants were explanted. Photographs and schematic drawings illustrate the macroscopic appearance of the regenerated tissue. Top 
row Representative photographs of regenerated tissue within the nerve guides (left hCNG‑group, right CFeCNG‑group). Center row Representative 
photographs of regenerated tissue after removal of the nerve guide (left hCNG‑group, right CFeCNG‑group with chitosan film still in place). Bottom 
row Schematic drawing of the regenerated tissue within the nerve guides (left hCNG‑group, right CFeCNG‑group), chitosan material is shown in 
blue. (1) Downwards-pointing in black indicating the outer edge of the chitosan nerve guide; (2) downwards-pointing in blue indicating the proximal 
and distal edge of the central chitosan film; (3) horizontal arrows in black indicating either single‑stranded (hCNG‑II) or double‑stranded (CFeCNG‑II) 
regenerated tissue; (4) red arrows point towards eventually vascularized tissue bridges between the two tissue cables in CFeCNGs
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Morphometric analysis
Three nerve segments of each group, harvested directly dis-
tal to the nerve guides (representative samples selected from 
animals with electrodiagnostically detectable motor recov-
ery, Additional file 4: Figure S4), were subjected to stereo-
logical and morpho-quantitative analysis on semi-thin and 
ultra-thin cross-sections. As depicted in Fig.  7, the cross-
sectional area was increased in the hCNG-II group (Fig. 7a), 
as was the total number of myelinated fibers (Fig. 7b), and 
the fiber density (Fig. 7c). But the differences were not sig-
nificantly different between the hCNG-II and CFeCNG-
II groups. Also size parameters (axon and fiber diameter, 
myelin thickness and g-ratio) were not different between 
the two experimental groups (Fig. 7d). Scatter plots display-
ing g-ratios of individual fibers in relation to their respective 
axon diameter also show no differences between groups and 
Fig. 5 Presentation of the morphological appearance of the regenerated tissue within the nerve guides. Schematic drawings and photomicro‑
graphs illustrate the morphology of the regenerates formed within the different nerve guides during 150 days after delayed reconstruction.  
A, B Schematic drawing of the regenerated tissue within the nerve guides, chitosan material is shown in blue (A hCNG‑II group, B CFeCNG‑II group). 
C, D Representative photomicrographs of trichrome‑stained cross‑sections through the regenerated tissue at distal location within the nerve 
guides (C hCNG‑II group, D CFeCNG‑II group). Yellow lines encircle areas of axonal regeneration as visualized in immunohistology (Fig. 6). Arrows 
indicate the location of the central chitosan film (B, D) and a tissue bridge that has formed through one of the holes in it connecting the two 
strands of the regenerate (D)
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regression line equations (hCNG-II: y = 0.0421 x + 0.5525; 
CFeCNG-II: y = 0.0408 x + 0.5395) with comparable slope 
and intercept (Fig. 7f). When performing the frequency dis-
tribution of nerve fiber diameters, by pooling all values from 
the analyzed samples, both distributions were unimodal, but 
axons that have been re-growing along the central chitosan 
film in CFeCNG-II nerve guides appeared with slightly 
increased axonal diameters (histograms of fiber diameter 
are shifted to the right for CFeCNG-II samples in compari-
son to hCNG-II samples, Fig. 7e).
In vitro differentiation of human monocyte derived 
macrophages cultured on chitosan films
To elucidate if the process of macrophage differen-
tiation contributes to the attenuated regeneration of 
peripheral axons along CFeCNGs after immediate [10] 
and also after delayed (current study) nerve reconstruc-
tion, we examined the differentiation behavior of mono-
cyte derived macrophages in response to the chitosan 
films. Therefore, monocytes were isolated from human 
peripheral blood mononuclear cells obtained from buffy 
coats by adherence. The experiment was designed under 
strong consideration of translation aspects, because the 
basic hCNGs have already been approved for clinical use 
(Europe and USA,  Reaxon® Nerve Guide) and were used 
in more than 100 human patients since market entry two 
years ago [10]. Consequently, we found it more appropri-
ate to investigate the chitosan effect on human peripheral 
blood-derived monocytes than on the same cells isolated 
from rat peripheral blood. Furthermore, chitosan effects 
on rat monocytes have already been described by others 
as will be discussed below.
Fig. 6 Immunohistology of cross‑sections through distal parts of regenerated tissue within the nerve guides. At 150 days after delayed nerve 
reconstruction, immunohistological analysis of cross‑sections through distal parts of the regenerated tissue within the nerve guides was performed. 
A, B Representative photomicrographs displaying the immunodetection of all regenerated axons (NF200 in green), regenerated motor axons (ChAT 
in red; co‑localization with NF200 is indicated in yellow) and nuclear staining in blue (DAPI). Arrows in (B) indicate the location of the central chitosan 
film and a tissue bridge that has formed through one of the holes in it connecting the two strands of the regenerate. C Quantification of axonal 
profiles revealed a tendency to increased numbers of motor axons in the CFeCNG‑II group. D The percentage of ChAT‑immunopositive motor axons 
is significantly increased in CFeCNG‑II samples (*p < 0.05). Error bars indicate mean ± SEM
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Comparing the composition of the cultures plated 
onto regular cell culture surfaces (non-coated bottom 
of 24-well cell culture plate, regular well ground, WG) 
or chitosan films with a degree of ~5% acetylation (CF) 
under different culture conditions revealed that the CFs 
used in our studies provided an immunomodulatory 
effect and stimulated the immediate differentiation of 
macrophages towards the reparative M2 phenotype.
Fig. 7 Nerve morphometry results of cross‑sections through distal nerve segments. At 150 days after delayed nerve reconstruction, morpho‑
quantitative analysis of nerve segments distal to the nerve guides was performed. a–d Histograms depicting the cross‑sectional area of the whole 
nerve section (a), the total number of myelinated fibers (b), the myelinated fiber density (c), and size parameters (axon and fiber diameter, g‑ratio 
and myelin thickness) (d). Values are expressed as mean ± SEM. e Scatter plots showing g‑ratios of individual myelinated axons as a function of axon 
diameter (obtained by pooling all values hCNG‑II: n = 283 analyzed axons; CFeCNG‑II: n = 250 analyzed axons). The lines represent linear regression 
lines. f Frequency distribution histograms of myelinated fiber diameters (obtained by pooling all values; hCNG‑II: n = 283 analyzed axons; CFeCNG‑
II: n = 250 analyzed axons). The two lines are the fitting lines of the distribution
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The differentiation towards the pro-regenerative M2 
phenotype is initiated by the extension of pseudopodia 
from the originally round cells. This goes along with cell 
elongation and the subsequent upregulation of specific 
cell surface markers [17]. As illustrated in Fig. 8, cultiva-
tion of human blood-derived monocytes on CFs triggered 
a change in cell morphology. Already 24 h after seeding, 
first elongating cells were detectable on CF in cultures 
without other external stimuli (non-stimulated condi-
tion, Fig. 8B). The cells increased their flattened area with 
time and extend pseudopodia (Fig. 8D, F) in contrast to 
cells grown under the same non-stimulated conditions 
on regular well grounds (WG, Fig. 8C, E). When the cul-
ture medium was, however, supplemented with M-CSF, a 
cytokine that is known to promote differentiation of M2 
macrophage phenotypes, also cells grown on WG devel-
oped pseudopodia (photomicrographs not shown).
Supplementation of M-CSF was used to simulate 
the immunomodulatory tissue conditions reported for 
peripheral nerves after injury, namely the anti-inflamma-
tory stimulus that induces differentiation of monocytes 
towards the pro-healing M2 macrophage phenotypes 
[18].
In parallel to the changes in cell morphology, we 
detected changes in the expression of the following cell 
surface markers. (1) The macrophage differentiation 
marker CD68. (2) The chemokine receptor CCR7 anti-
gen, present on the pro-inflammatory M1 macrophage 
subtype. (3) The scavenger receptor CD163 for which an 
increased expression is related to the M2a macrophage 
Fig. 8 Morphology of macrophages cultivated on regular well grounds (WGs) or chitosan films (CFs). Representative photomicrographs on the 
morphological changes of macrophages cultivated either on WG (A, C, E) or CF (B, D, F). Displayed pictures indicate a strong time‑dependency 
[e.g. at 24 h (A, B), 48 h (C, D), and 96 h (E, F)] of morphological changes of the macrophages cultivated on CFs. Scale bar represents 50 µm for all 
pictures
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subtype, and (4) the CD206 alpha-mannose receptor, 
which is present on anti-inflammatory M2a and M2c 
macrophage subtypes [19]. The expression profiles of the 
analyzed markers are depicted in Figs. 9 and 10.
Results reveal that all macrophages independent of the 
different cultivation conditions expressed relatively con-
stant levels of the macrophage differentiation marker 
CD68 (Figs. 9a, 10a).
The expression of the M1 macrophage marker CCR7 
was not modulated before day 8 in culture (Figs. 9b, 10b), 
when a significant up-regulation was observed on non-
stimulated cells cultured on WG. The lowest expression 
level was detectable in the M-CSF stimulated cultures on 
WG, while non-stimulated and stimulated cultures on CF 
showed a balanced expression level.
Analysis of the cell surface expression of CD163 
revealed an upregulation on non-stimulated (significant 
from day 4 onward) and on M-CSF-stimulated mac-
rophages seeded on WG (Figs.  9c, 10c). Macrophages 
cultured under both conditions on CF appeared to inhibit 
the up-regulation of this marker.
After 48 h in culture under non-stimulated conditions 
on CF, a strong upregulation of CD206 expression was 
detected (Figs. 9d, 10d). As expected, M-CSF induced an 
even more pronounced upregulation of this marker on 
macrophages cultured on regular WG (significant after 
2 and 4 days in culture, Figs. 9d, 10d). Interestingly, the 
addition of M-CSF to macrophages cultured on CF did 
not strengthen the stimulatory effect, but in contrast 
a supposed explosive up-regulation was balanced to 
the same level seen in the non-stimulated CF condition 
(Figs. 9d, 10d). At later time points, i.e. 96 h and 8 days 
after plating, the differences between WG and CF related 
effects on the expression of CD206 under non-stimulated 
conditions were not detectable anymore (Fig. 10d). This 
is possibly an indirect effect due to the secretion of dif-
ferent cytokines by the cells and a subsequent attenuation 
of the biomaterial effect or the development of a homeo-
stasis. Noteworthy is, however, that while M-CSF was 
still stimulating the CD206 expression on cells cultured 
on WG, chitosan kept on exerting the immunoregulatory 
effect when cells cultured on CF were supplemented with 
M-CSF (Fig. 10d).
Discussion
Promising designs of novel nerve guides are usually 
examined in animal models using immediate reconstruc-
tion of peripheral nerve defects [20], but to our knowl-
edge, none of the innovative designs has been recently 
tested after delayed nerve reconstructions in healthy and 
diabetic conditions. The diabetic condition represents 
an increasing prevalence in the human population and 
is inflicted with a reduced health and maintenance of the 
peripheral nervous system. In delayed nerve reconstruc-
tions, resection of scarred nerve tissue often results in 
an enlarged defect distance between the separated nerve 
ends. These kinds of defects have to be bridged by e.g. 
autologous nerve grafts. However, harvesting an unin-
jured nerve to support regeneration of a more important 
injured nerve trunk may not always be acceptable for the 
patient (e.g. prolonged surgery time, second surgery site, 
loss of function of the donor nerve). Therefore, nerve 
guides may be a suitable alternative to bridge shorter 
defects in delayed reconstruction; not only for the risk of 
residual problems from the donor side, but also for short-
ening the time for surgery. With regard to the systemic 
health conditions of the respective patients, it has to be 
considered that patients with diabetes may be in need of 
specific nerve guides others than those used for generally 
healthy patients. This is due to the fact that in diabetic 
neuropathy there are signs of both degeneration and 
regeneration (seen as regenerative clusters) and the gen-
eral opinion is that nerve regeneration is impaired after a 
complete nerve injury and reconstruction in experimen-
tal systems [21]. Due to the potential increasing number 
of patients with diabetes, who have a broad spectrum of 
professional activities and may also injure their nerves by 
a trauma, any type of medical device should investigate 
the possibility to apply the device in diabetic conditions 
for which the diabetic GK rat represents an appropriate 
model resembling type 2 diabetes.
We have earlier demonstrated that the supportive 
properties of hCNGs are increased in CFeCNGs under 
immediate reconstruction conditions in both healthy 
and diabetic rats [10]. In the current study, we extended 
the focus to a comprehensive evaluation of the degree 
of early regeneration associated events and subsequent 
functional recovery after a delayed reconstruction of a 
15 mm rat sciatic nerve gap with either one-chambered 
hollow hCNGs or two-chambered CFeCNGs in healthy 
Wistar rats and diabetic GK rats. The “deadline”, when 
a delayed nerve reconstruction in healthy or in diabetic 
conditions, irrespective of in experimental models or 
in clinical practice, can be done, is not clear. In the lit-
erature, it is not well defined what the best timing is to 
perform a study on delayed peripheral nerve reconstruc-
tion. We used a 45  days delay since it is sufficient time 
to induce biological effects in the peripheral (and central) 
nervous system with an impaired nerve regeneration pro-
cess [22–24], but at a time point where there are minor 
risks for residual problems in the rats, e.g. risk for foot 
ulcers due to an unrepaired nerve injury. Furthermore, a 
term of 4 weeks up to 2 months of chronic denervation 
is, however, determined to be affiliated with considerable 
changes in the capacity of Schwann cells to support the 
regeneration process [25, 26]. The presently chosen delay 
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Fig. 9 Cell surface marker expression profiles of non‑stimulated or M‑CSF‑stimulated macrophages differentiated on CFs or WGs. Macrophages, 
cultivated for up to 2 days under different conditions, were harvested and stained with CD68‑ (macrophage differentiation marker independent of 
M1/M2 phenotype), CCR7‑ (M1 phenotype), CD163‑ (M2a phenotype) and CD206‑antibodies (M2a and M2c phenotype) followed by FACS analysis. 
a The gate was set on the FSC versus SSC to analyze monocyte‑derived cells and exclude dead cells and cell debris. b Surface expression of CCR7 
and intracellular expression of CD68. c Surface expression of CD163 and intracellular expression of CD68. d Surface expression of CD206 and intra‑
cellular expression of CD68 FSC forward scatter, SSC side scatter, WG well ground, CF chitosan film (n = 4 experiments)
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period was based on these findings, and because it clearly 
exceeds the minimum period of 4 weeks (30 days). How-
ever, the generally insufficient nerve regeneration after a 
delayed nerve reconstruction can be attributed not only 
to an inability of Schwann cells to support axonal out-
growth, but also to alterations in the response of motor 
and sensory neurons to the injury [10, 24, 27].
In the current study, both examined nerve guides dem-
onstrate their support of nerve regeneration across a 
critical defect length in healthy as well as in diabetic con-
ditions even after a delayed nerve reconstruction, in spite 
of a variation in the formation of the regenerative matrix 
in the models as observed 56  days after reconstruction. 
As expected, the preoperative blood glucose levels posi-
tively correlated with the percentage of cleaved caspase-3 
immunopositive Schwann cells in the distal nerve seg-
ment, indicating a higher risk for Schwann cells being 
apoptotic in conditions with higher blood glucose levels. 
The latter conditions appeared to be recapitulated in the 
delayed reconstruction scenario although the initial tran-
section injury occurred 45  days before the reconstruc-
tion. During reconstruction, however, both nerve ends 
are manipulated (cut) again as 2  mm of the previously 
stitched up nerve ends are removed in order to insert 
clean nerve ends into the nerve guides. The HSP-27 
expression in analyzed sections of dorsal root ganglia on 
the control side negatively correlated with the preopera-
tive blood glucose levels as well as with the presence of 
cleaved caspase-3 immunopositive Schwann cells in the 
distal nerve segment, indicating a detrimental effect of a 
high blood glucose level and apoptotic cells on a neuro-
protective substance. However, the diabetic condition did 
finally not affect the presence of axons in the distal nerve 
segment, as neurofilaments were present essentially to 
the same extent as in the healthy Wistar rats at 56 days 
after the delayed nerve reconstruction. This indicates that 
the condition of delayed nerve reconstruction did already 
modify the regenerative milieu and probably alleviate the 
difference between the healthy and the diabetic condi-
tion. We were only able to just detect (i.e. present or not) 
neurofilaments in the distal nerve segment. We could not 
securely measure the length of outgrowth or the amount 
of fibers to get a more detailed view of the regeneration 
in the short-term comparison [11, 14] because longitudi-
nal sections were prepared in order to primarily analyze 
ATF-3 and cleaved caspase-3 immunopositive cells in 
the distal nerve segment. Furthermore, we could not fol-
low all the neurofilaments across the conduits due to the 
variations in the formed regenerative matrices (i.e. sin-
gle- and double-strand matrices or non-complete matrix; 
in the latter probably axonal growth along the wall of the 
conduit). Irrespective of this, we observed neurofilament 
immunopositive axons in the distal nerve segment indi-
cating that the use of chitosan nerve guides is as valid in 
diabetic as in healthy conditions.
Similar to our previous findings [10], through the 
long-term observation we detected again an advantage 
of CFeCNGs over hCNGs with regard to the support of 
overall tissue regeneration and percentage of animals per 
group displaying functional motor recovery. The onset 
and progress of functional recovery and its degree, how-
ever, are considerably retarded and less complete, respec-
tively, than after immediate nerve reconstruction. This 
indicates again the importance of prompt nerve recon-
struction after injury [22, 28]. The course of functional 
recovery detected in the current study is likely related to 
the thin regenerative matrix formed during the 56  days 
after delayed nerve reconstruction of the 15 mm critical 
defect lengths with either type of nerve guide examined, 
i.e. hCNG or CFeCNG. The formation of a regenerative 
matrix crucially determines the outcome of peripheral 
nerve regeneration through bioartificial nerve guides [15, 
29]. Our results indicate that this formation of a regen-
erative matrix is disturbed after a delayed nerve recon-
struction both in healthy and diabetic conditions.
We observed a higher number of activated ATF-3 as 
well as apoptotic cleaved caspase-3 immunopositive 
Schwann cells after delayed nerve reconstruction (cur-
rent study) compared to immediate nerve reconstruc-
tion across this extended nerve defect (15  mm) even 
if the evaluation period was similar, i.e. 56  days post-
surgery [10]. We have no explanation for this observa-
tion other than that the manipulation of the nerve ends 
during surgical nerve reconstruction could have influ-
enced the cell behavior. In general, one would expect a 
lower percentage of stained Schwann cells, as verified 
(See figure on previous page.) 
Fig. 10 Characterization of cell surface markers of non‑stimulated or M‑CSF‑stimulated macrophages differentiated on CFs or WGs. Macrophages 
were differentiated for 2, 4, and 8 days in vitro under different conditions, harvested and stained with CD68‑ (macrophage differentiation marker 
independent of M1/M2 phenotype), CCR7‑ (M1 phenotype), CD163‑ (M2a phenotype) and CD206‑antibodies (M2a and M2c phenotype) before 
FACS analysis. Graphs represent the geometric mean fluorescence intensities (MFI) values of FSC versus SSC or CD68 positive gated cells for the 
indicated cell surface markers. a Expression levels of CD68 (Gate FSC vs. SSC). b Expression levels of CCR7 (Gate CD68 positive cells). c Expression 
levels of CD163 (Gate CD68 positive cells). d Expression levels of CD206 (Gate CD68 positive cells). WG well ground, CF chitosan film (n = 4 for each 
condition, medians are indicated). *p < 0.05 and **p < 0.01 compared to WG at the same time point, ###p < 0.001 compared to all other samples at 
the same time point
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by the double-staining (Additional file 2: Figure S2) and 
the previously used method of analysis [22, 23], after a 
delayed nerve reconstruction [27]. A low percentage of 
activated Schwann cells is due to a transient upregula-
tion of different factors supporting nerve regeneration 
over time with subsequent impaired ability of Schwann 
cells to stimulate regeneration after a delayed nerve 
reconstruction [22, 24, 30]. The proportions of ATF-
3, i.e. activated, and cleaved caspase-3, i.e. apoptotic, 
stained Schwann cells probably balance each other in 
numbers; thus, if more activated cells are available in a 
nerve segment the more apoptotic cells may occur [11, 
14], although no positive correlation could be detected 
in the current study.
Furthermore, even if neurofilament immunopositive 
axons were present in the distal nerve segment of all 
rats in the groups examined 56 days after the delayed 
reconstruction, the regrowing axons appeared to be less 
sufficient or too low in numbers to properly regain func-
tion in comparison to the conditions after an immediate 
nerve reconstruction. Indeed, the number of myelinated 
axons detected in nerve morphometry of distal nerve 
segments after long-term evaluation in the current study 
was reduced to approximately 50% of the values detect-
able after immediate nerve reconstruction [10]. With 
regard to functional recovery, the tibialis anterior mus-
cle CMAP amplitude ratio, for example, recovered to 
about >20–40% in more than 50% of the sciatic nerves 
immediately reconstructed with CFeCNGs [10]. After a 
45-day delay of reconstruction, we found a recovery of 
only 10–30% for most sciatic nerves reconstructed with 
CFeCNGs. This, again, indicates the importance of a 
timely reconstruction of injured peripheral nerves [22, 
24, 30]. Whenever immediate nerve reconstruction is not 
an option, however, the nerve guides used for a delayed 
approach should still support the regeneration process.
Indeed, our immunohistological results indicate a 
specific promotion of the regrowth of ChAT-immunop-
ositive motor axons by the chitosan film centrally intro-
duced to the CFeCNGs. This finding could eventually be 
strengthened by the morphometric results displaying a 
slightly increased diameter of axons regenerated through 
CFeCNGs. Although it has already been demonstrated 
a few years ago that introducing a central biomaterial-
film into a hollow tube can improve nerve regeneration 
through the same [31], it is very likely that the specific 
chitosan film used within the CFeCNGs provided a spe-
cific growth support. Specific differentiation of the mac-
rophage population into a M2-phenotype dominated 
population of regulatory and healing macrophages at 
the injury site or within the nerve guide [32] has been 
accounted responsible for improved peripheral nerve 
regeneration. Furthermore, 3D scaffolds made out of 
chitosan with a similar degree of ~5% acetylation as of 
the chitosan material applied in the current study, pro-
voked an inflammatory response after their subcutane-
ous implantation in mice that was characterized by high 
numbers of reparative M2 macrophages adherent to 
the scaffolds and increased levels of anti-inflammatory 
cytokines within the exudates at the implantation site 
[13]. Several studies indicate that biomaterials can pro-
vide an immunomodulatory stimulus [32] and that their 
biophysical and mechanical properties impact the dif-
ferentiation and subsequent polarization of macrophage 
subtypes [33] within the pro- or anti-inflammatory 
response to tissue injury. Macrophage subtypes repre-
sent distinct functional phenotypes that are continuously 
formed in response to changes in the cells microenvi-
ronment [33]. When arriving from the peripheral blood 
at the site of a peripheral nerve injury or in the distal 
nerve end, an inherent pro-regenerative milieu develops 
that induces an M2 phenotype [18, 34]. This represents 
a first step towards axon and Schwann cell modulations 
that can finally lead to stimulation of the peripheral nerve 
regeneration process not only in the distal nerve end, but 
also in a nerve conduit or in an autologous nerve graft 
[32, 35].
Our in  vitro results provide an insight into the 
mechanism(s) by which the chitosan biomaterial can spe-
cifically support the peripheral nerve regeneration process 
when introduced into chitosan nerve guides as a central 
chitosan film. Although we are not the first describing the 
immunomodulatory effect of chitosan, others have been 
investigating it in the context of subcutaneous implant-
able device surfaces [13, 19]. In accordance to these earlier 
data, we clearly demonstrate that our chitosan films trig-
ger the differentiation of monocyte-derived macrophages 
from human blood samples towards the pro-regenerative 
M2 phenotype. Macrophages [35], and in particular the 
M2 macrophage phenotype, have previously been attrib-
uted to provide crucial support for peripheral nerve 
regeneration [12]. Furthermore, chitosan with a degree 
of acetylation of 5%, similar to that in our study, was spe-
cific in this pro-regenerative immunomodulation after 
subcutaneous application of the biomaterial, while a 
higher degree of acetylation induced a pro-inflammatory 
response [13]. Also, in line with previous results [19] from 
in  vitro analysis of human primary monocyte-derived 
macrophages cultured on chitosan films with a degree 
of acetylation of ~10%, we demonstrate high expression 
of CD206 paralleled by a low expression rate of CD163 
in our cells, indicating that chitosan specifically triggers 
the M2c subtype polarization. While CD206 is expressed 
on both the M2a and M2c subtype, CD163 is expressed 
more on M2a macrophages [19]. Both subtypes are likely 
to support peripheral nerve regeneration through our 
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chitosan nerve guides because both are known to secrete 
growth factors to support angiogenesis and tissue regen-
eration [33]. Here and earlier [10], we demonstrated that 
the regenerated tissue formed in CFeCNGs is better vas-
cularized in comparison to that developed in hCNGs. 
Furthermore, the M2c macrophage subtype has an impact 
on the extracellular matrix remodeling [33], and this 
event is crucial during the early phase of peripheral nerve 
reconstruction with nerve guides. As already mentioned 
above, the successful formation of the regenerative matrix 
is needed for successful peripheral nerve regeneration 
[15, 29] and again, the current study demonstrates that 
this process is supported by CFeCNGs in comparison to 
hCNGs not only after immediate nerve reconstruction 
[10] but also after a delayed nerve reconstruction.
Conclusions
The presented results clearly indicate that, in compari-
son to hCNGs, CFeCNGs provide an increased support 
of motor axon regeneration after delayed nerve recon-
struction. The tested nerve guides alone are, however, not 
sufficient to support a degree of axonal and functional 
motor recovery similar to that after immediate nerve 
reconstruction. It is, however, a known fact that nerve 
regeneration after delayed reconstruction is impaired [36, 
37] and the possible strategies to improve it range widely 
from targeting molecular cues [38] to supplementary 
treatment strategies, like intra-surgical electrostimula-
tion or rehabilitation exercise [36].
To more deeply analyze the mechanism(s) behind 
the specific support of motor axon regeneration by 
the chitosan material in CFeCNGs, and not in hCNGs, 
could, however, provide helpful indications for future 
modifications of the nerve guides in order to make 
them qualified products also for delayed nerve recon-
struction in healthy and diabetic conditions with the 
intention also to improve the formation of the regen-
erative matrix.
Obviously, not only the biochemical, but also the bio-
physical and mechanical cues, provided by the biomaterial 
used for peripheral nerve reconstruction have to be care-
fully concerned in healthy and diabetic conditions when 
tissue engineering approaches should lead to an optimized 
remodeling of the physiological conditions provided by 
autologous nerve grafts. Chitosan, however, represents 
a valuable biomaterial for future research as it has clearly 
demonstrated also significant immunomodulatory effects.
With regard to a potential need of nerve guides spe-
cific for patients with diabetes, our current results indi-
cate that this cannot be focused on further at this stage of 
research, because the delayed nerve reconstruction con-
dition did not result in considerable differences between 
healthy and diabetic subjects.
Methods
Manufacturing of one‑chambered hollow chitosan 
nerve guides (hCNGs) and two‑chambered chitosan film 
enhanced chitosan nerve guides (CFeCNGs)
Chitosan was extracted from Pandalus borealis shrimp 
shells and further processed to certified medical grade 
by Altakitin S.A. (Lisbon, Portugal). Afterwards, hol-
low chitosan nerve guides (hCNGs; length: 19  mm, 
inner diameter: 2.1  mm;  REAXON® Nerve Guide) and 
chitosan films (CFs) were produced according to ISO 
13485 requirements by Medovent GmbH (Mainz, Ger-
many) with a final degree of acetylation (DA) of ~5% as 
previously described [7]. Chitosan film enhanced chi-
tosan nerve guides (CFeCNGs) were manually made up 
as described earlier [10]. In brief, they are composed of 
rectangular pieces (length: 15 mm, width: 5 mm) of per-
forated (along the midline of the longer axis, diameter 
of perforation: 0.3 mm, distance in between: 2 mm) and 
subsequently Z-shape-folded CFs (opposite kinked edges, 
width of outer edges: 1.5 mm) that were introduced into 
the lumen of hCNGs leading to 2 mm spaces on each site. 
Before application, hCNGs and CFeCNGs were sterilized 
by electron beam.
Animals and surgical procedure
All experimental protocols were approved by the local 
authorities (Animal Ethics Committee in Malmö/Lund, 
Sweden, reference number M-347-11 and M131-14, and 
animal care committee of Lower-Saxony, Germany: Nds. 
Landesamt für Verbraucherschutz und Lebensmittelsi-
cherheit Dezernat 33/Tierschutz, reference number 33.12 
42502-04-12/0816).
The animal experiments were performed in two dif-
ferent laboratories [Dahlin lab at Lund University 
(ULUND), Sweden, and Grothe lab at Hannover Medical 
School (MHH), Germany] using different animal breed-
ers and regimes for anesthesia and analgesia based on 
different national rules for the care and use of labora-
tory animals. In common, adult female Wistar rats with 
an average weight of 220–285  g were housed in pairs 
of two animals (MHH) or in groups of four (ULUND) 
under standardized housing conditions [room tempera-
ture 22.2 °C; humidity 55.5%; light–dark cycle 14 h/10 h 
(MHH) or 12  h/12  h (ULUND)]. Adult female Goto-
Kakizaki rats (GK rats) were kindly provided by Malin 
Fex, Lund University, Sweden, with an average weight 
around 230  g. Food and water was provided ad  libi-
tum, with providing extra water for the diabetic GK 
rats at ULUND. At MHH, water was supplemented 
with amytriptiline hydrochloride (13.5 mg/kg/day, Ami-
triptylin-neuraxpharm®; Neuraxpharm Arzneimittel 
GmbH, Germany) during the whole experiment starting 
4 weeks prior to the initial transection surgery to reduce 
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the possibility of occurring automutilation as known 
from literature [39]. Once weekly, fasting blood sugar 
was determined in the rats at ULUND. Therefore blood 
harvested from the tail vein was analyzed [Ascensia con-
tour™ (Bio health Care, USA, Bio Diagnostics Europe) 
and LT (Bayer AB, Diabetes Care, Solna, Sweden); test 
slips Microfil™ (Bio Healthcare Diabetes Care, USA)].
All surgical interventions and non-invasive electrodi-
agnostic recordings were performed under aseptic con-
ditions with sufficient anesthesia and analgesia applied. 
At ULUND, anesthesia was induced by intraperitoneal 
injection of Rompun (20 mg/ml, Bayer Health Care, Ger-
many) and Ketalar (10 mg/ml, Pfizer, Finland) at a dose 
of 0.125  ml/kg bodyweight. Post-operative pain was 
relieved by intramuscular injection of buprenorphine 
of 0.01–0.05  mg/kg bodyweight (0.3  mg/ml,  Temgesic®; 
Schering-Plough Europe, Belgium). At MHH, anesthe-
sia was induced by intraperitoneal injection of chloral 
hydrate (370  mg/kg, Sigma-Aldrich Chemie GmbH, 
Germany) and for surgical interventions, sufficient anal-
gesia was ensured by locally applied bupivacaine (0.25%, 
 Carbostesin®; AstraZeneca GmbH, Germany) and lido-
caine (2%,  Xylocain®; AstraZeneca GmbH, Germany) on 
the exposed nerve and subcutaneous injection of butor-
phanol (0.5 mg/kg,  Torbugesic®; Pfizer GmbH, Germany) 
at the day of surgery and two post-operative days. For 
electrodiagnostic measurements, sufficient analgesia was 
achieved by intramuscular injection of buprenorphine 
(0.045 mg/kg,  Temgesic®; Bayer Vital GmbH, Germany).
For nerve transection surgery, the left sciatic nerve 
was exposed at mid-thigh level as previously described 
[7, 10, 11] and cut with micro-scissors at a constant level 
(2.5  mm distal to the aponeurosis) without removing 
any nerve tissue. To prevent spontaneous recovery, both 
nerve ends were sutured in a loop-like shape (Additional 
file  1: Figure S1, 9-0 Ethilon, EH7981G, Ethicon, Scot-
land) resulting in an initial gap of 6 mm in between the 
nerve ends. After 45  days, the transected sciatic nerve 
was re-exposed and the nerve ends found to be approxi-
mately 11  mm apart from each other. The nerve ends 
were each refreshed by resecting 2  mm of the scar tis-
sue loop and the nerve ends sutured with one epineurial 
stitch at each end (9-0 Ethilon) into the respective nerve 
guide with an overlap of 2 mm. Before nerve reconstruc-
tion with either hCNG or CFeCNG, the nerve guides 
were softened in 0.9% sodium chloride solution (NaCl 
0.9%, B. Braun Melsungen GmbH, Germany) for at least 
20 min.
Analysis of the regenerative matrix at 56 days after delayed 
nerve reconstruction (study I)
In study I, the reconstructed sciatic nerve was dissected 
together with the used nerve guide at 56  days after 
delayed nerve reconstruction. The contents of the nerve 
guides (e.g. the regenerative matrix, if formed) together 
with the respective proximal and distal nerve ends were 
processed for sectioning using a cryostat as described 
before [7, 10, 11, 14]. Blind-coded, longitudinal sec-
tions at 4  µm thickness were collected on Super  Frost® 
plus glass slides (Menzel-Gläser, Germany) and immu-
nohistology was performed to evaluate (1) presence of 
axons by neurofilament staining [anti-human neurofila-
ment protein (DAKO Glostrup, Denmark), 1:80 in 0.25% 
Triton-X 100 and 0.25% FCS in phosphate buffered salt 
solution (PBS)/Alexa Fluor 594 conjugated goat anti-
mouse IgG (Invitrogen, Molecular Probes, USA), diluted 
in 1:500 in PBS], and (2) activated Schwann cells, and (3) 
apoptotic Schwann cells, respectively, by anti-activating 
transcription factor 3 (ATF-3) and anti-cleaved caspase-3 
staining [rabbit anti-ATF-3 polyclonal antibody (1:200; 
Santa Cruz Biotechnology, USA) or anti-cleaved cas-
pase-3 antibody (1:200; Invitro Sweden AB, Stockholm, 
Sweden); both diluted in 0.25% Triton-X 100 and 0.25% 
FCS in PBS/Alexa Fluor 488 conjugated goat anti-rab-
bit IgG (Invitrogen, Molecular Probes, USA), diluted in 
1:500 in PBS]. The Schwann cells were identified on their 
location and the oval shaped nuclei [14, 30]. Furthermore, 
double-staining for ATF-3 or cleaved caspase-3 and 
S-100 was additionally performed in single experiments 
as earlier described [30]. Finally, the slides were mounted 
with 4′,6′-diamidino-2-phenylindole DAPI  (Vectashield®, 
Vector Laboratories, Inc. Burlingame, USA) to visualize 
the nuclei (i.e. for counting the total number of the cells) 
and cover slipped.
As earlier described [7, 10, 11, 14], in digitalized sec-
tions, the presence of outgrowing axons was classified as 
present or non-present in three randomly selected sec-
tions in the distal nerve segment just distal to the distal 
suture line. Cells immunopositive for cleaved caspase-3 
and ATF-3 were counted in one section (image size 
500 × 400 µm) at three different levels in the matrix and 
in the adjacent sciatic nerve: at 3 mm from the proximal 
nerve suture, in the center of the formed matrix in the 
nerve guides and in the distal nerve segment. The same 
squares were also used for counting the total number of 
DAPI stained cells (no/mm2). The images (20× magnifi-
cation) were analyzed with NIS elements (Nikon, Japan).
Assessment of sensory dorsal root ganglia at 56 days 
after delayed nerve reconstruction (study I)
Together with harvest of the nerve guide content at 56 
days after delayed nerve reconstruction, the dorsal root 
ganglia (DRGs) L4 and L5 were collected bilaterally and 
processed on the cryostat into longitudinal sections 
(8  µm thickness) collected on Super  Frost® plus glass 
slides (Menzel-Gläser, Germany). The DRG sections were 
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air dried, washed in PBS for 15 min, and thereafter incu-
bated for ATF-3 immunohistology (protocol as above) or 
incubated with a primary goat-anti-Heat Shock Protein 
27 antibody [HSP-27, sc-1048, Santa Cruz Biotechnol-
ogy, USA; dilution 1:200 in 0.25% Triton-X 100 (Sigma-
Aldrich, USA) and 0.25% bovine serum albumin (BSA; 
Sigma-Aldrich, USA)] in PBS overnight at 4 °C. The anti-
HSP-27 antibody was detected with the secondary Alexa 
Fluor 488 donkey anti-goat antibody (Molecular Probes, 
Eugene, Oregon, USA; dilution 1:500) in PBS for 2  h at 
room temperature followed by a further wash with PBS 
for 3 × 5 min. Finally, these sections were cover-slipped 
with  Vectashield® (Vector Laboratories, CA, USA) con-
taining DAPI for counterstaining of the nuclei for eval-
uation of cell activation (i.e. ATF-3) and presence of 
the neuroprotective substance Heat Shock Protein 27 
(HSP-27).
Photomicrographs were taken at 20× magnification 
and imported into ImageJ (http://imagej.nih.gov/ij/) in 
order to analyze the presence of ATF-3 activated sen-
sory neurons and the expression of the neuroprotective 
HSP-27 in the DRGs as earlier described [10, 22]. ATF-3 
stained sensory neurons were quantified and expressed 
as percent of total number of sensory neurons (i.e. DAPI 
stained cells). A region of interest (ROI) covering 75 × 75 
pixels was determined to analyze HSP-27 expression. The 
tool threshold was used to determine the immunolabel-
ling with the intensity threshold decided by adding three 
times the standard deviation of the background to the 
mean intensity (x¯ + 3 × SD). Measurement of the immu-
nopositive area was performed across the entire section 
and expressed in percent of the total area of the section 
containing cell bodies; thus both, intensity of neurons and 
their satellite cells, as well as in thin axons, were included. 
Furthermore, the HSP-27 expression was also expressed 
as a ratio; i.e. percent HSP-27 at the experimental side 
divided by the expression on the control side [10].
Assessment of functional motor recovery over a period 
of 150 days after delayed nerve reconstruction (study II)
Non‑invasive electrodiagnostic recordings
Non-invasive electrodiagnostic recordings were per-
formed as described earlier [7, 10] every 30 days after the 
delayed reconstruction surgery starting on 60 days post-
reconstruction. In short, the animals were anesthetized, 
placed in prone position and the body temperature kept 
on a constant level. Transcutaneous monopolar needle 
electrodes delivered single electrical impulses (100  µs 
duration with supramaximal intensity at 1 Hz frequency) 
to the reconstructed sciatic nerves either at the sciatic 
notch (proximal stimulation site) or into the popliteal 
fossa (distal stimulation site). Compound muscle action 
potentials (CMAP) were recorded for both sides of each 
individual (left reconstructed side and healthy side as 
control) from the tibialis anterior (TA) or the plantar 
interosseus muscles (PL) using a Keypoint portable sys-
tem (Natus Europe, Germany). To evaluate the degree 
of reinnervation, latencies and amplitudes of the evoked 
CMAPs were taken into account and ratios calculated 
(lesioned side divided by non-lesioned side). If no evoked 
CMAPs could be detected, amplitude ratios were set to 
“0” value but still included into the statistical analysis.
Muscle weight ratio
After final functional analysis at 150  days after delayed 
nerve reconstruction, the animals were sacrificed and 
the tibialis anterior and gastrocnemius muscles har-
vested from both sides and weighted. The muscle weight 
ratio of each animal was calculated by muscle weight 
[g] on lesioned side divided by muscle weight [g] on 
healthy side. All values were included in statistical anal-
ysis irrespectively of the results obtained in either elec-
trodiagnostic measurements or individual macroscopic 
regeneration outcome.
Nerve immunohistology and histomorphometry 150 days 
after delayed nerve reconstruction (study II)
Nerve (immuno‑)histochemistry
After final assessment of functional motor and sensory 
recovery, animals were sacrificed and the nerve guides 
together with the regenerated tissue were harvested for 
further investigation. The macroscopic appearance of 
the regenerated nerve tissue was assessed after remov-
ing the chitosan nerve guides. Afterwards, the nerve 
tissue (in case of CFeCNGs together with the central chi-
tosan films) was fixed overnight in 4% paraformaldehyde 
in PBS at 4  °C for subsequent paraffin-embedding and 
(immuno-)histological evaluations. One series of eighty 
blind-coded sections with a thickness of 7 µm each was 
prepared within the distal part of the regenerated tissue 
(560 µm segment from 12.7 to 13.3 mm distal to the orig-
inal proximal nerve end). The sectioning was initiated 
3.7  mm proximal to the distal end of the nerve guides 
and continued in proximal direction. Therefore, in case 
of CFeCNGs, the sections included the most distal perfo-
ration within the chitosan films. To visualize the general 
tissue histology, sections were subjected to trichrome 
(collagen) staining as described before [10]. In brief, sec-
tions were consecutively processed with hemalum solu-
tion acid according to Mayer (Roth, Germany), staining 
solution containing acetic acid (1% in  H2O) and acetic 
fuchsine (0.5% in 1% acetic acid, both Merck, Germany) 
mixed with light green (1% in 1% acetic acid, Chroma 
Gesellschaft, Schmidt & Co., Germany) and wolfram-
ite phosphoric acid (1% in  H2O, Merck, Germany), and 
finally 1% acetic acid.
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For immunohistology, sections successive to the ones 
processed in trichrome staining were double-stained for 
neurofilament and choline acetyltransferase (ChAT) as 
previously described [10]. Briefly, as first blocking solu-
tion we used in 5% horse serum diluted in PBS prior to 
incubation with the following primary-secondary anti-
body combination: goat anti-ChAT antibody (1:50, in 
blocking solution, AB144P, Millipore, Germany) detected 
by Alexa Fluor 555-conjugated donkey anti-goat anti-
body (1:500, in blocking solution, A21422, Invitrogen, 
Germany). The second blocking solution was 3% milk 
powder/0.5% Triton-X 100 in PBS. Primary rabbit anti-
NF200 antibody (against phosphorylated NFeH, 1:500, in 
blocking solution, N4142, Sigma-Aldrich, Germany) was 
detected by Alexa Fluor 488-conjugated goat anti-rabbit 
antibody (1:1000, in blocking solution, A11034, Invitro-
gen, Germany). Nuclear counterstaining was achieved 
with DAPI (1:2000, in PBS, Sigma-Aldrich, Germany).
Representative photomicrographs of the processed 
and mounted sections were taken as multiple image 
alignments (MIA) with the help of a BX51 microscope 
(Olympus, Germany) expanded with a joystick controlled 
microscope stage (MBF Bioscience, USA) and the Ste-
reo Investigator software version 11.07 (MBF Bioscience, 
USA). Exposure time was adjusted for each staining and 
channel and held constant for microscopy of different 
sample sections making them comparable in a quantita-
tive manner. For the quantification of NF200- and ChAT-
immunopositive profiles, ImageJ version 1.48 (National 
Institutes of Health, USA) was applied. NF200-immu-
nopositive areas were employed to define the regions of 
interest (ROI), which were later used for quantification 
of particle number. Next, binary images were gener-
ated from NF200-photomicrographs using a threshold 
strategy allowing for distinction of individual nerve fib-
ers. The same threshold was applied to all samples. Simi-
larly, ChAT-images were transformed to binary images. 
Now, the particle analysis function of ImageJ was used 
for detection of NF200-positive nerve fibers within the 
ROI. Noise was reduced by excluding particles with a size 
smaller than 0.001  Pixel2. Similarly, motor neuron fib-
ers, which are positive for both, NF200 and ChAT, were 
detected on a binary image generated by multiplication 
of the NF200- and ChAT-binary images using the image 
calculator function of ImageJ. This allows for exclusion of 
unspecific ChAT-immunopositive signals from the quan-
tification process. Only animals showing an evocable 
CMAP were included and analyzed at the same site of the 
regenerated tissue.
Resin embedding and electron microscopic analysis
Distal nerve segments (5  mm long tissue samples har-
vested from the nerve directly distal to the nerve guides) 
were fixed by immediate immersion in glutaraldehyde 
(2.5% in 0.1 M phosphate buffer saline pH 7.4) for 4–5 h 
at 4  °C. Samples were then post-fixed in 2% osmium 
tetroxide for 2 h and dehydrated through a graded series 
of ethanol from 30 to 100%. Thereafter, samples were 
infiltrated with propylene oxide (two passages of 7  min 
each) and then immersed in a 1:1 mixture of propylene 
oxide and Glauerts’ mixture of resins (made of the same 
part of Araldite M and the Araldite Harter, HY 964) over-
night. The following day, samples were embedded in 
Glauerts’ mixture of resins where 0.5% of the plasticizer 
dibutyl phthalate and 2% of accelerator 964 were added. 
Nerve samples were finally oriented in embedding molds 
and left 48 h at 60 °C for polymerization.
Semi-thin sections of 2.5 µm were cut using an Ultracut 
UCT ultramicrotome (Leica Microsystems, Wetzlar, Ger-
many) and stained with 1% toluidine blue. A DM4000B 
microscope equipped with a DFC320 digital camera and 
an IM50 image manager system (Leica Microsystems, 
Wetzlar, Germany) was used for section analysis.
Ultrathin sections of 70  nm were cut with a diamond 
knife (Diatome, UK) and collected on copper grids coated 
with Pioloform film. Sections were counter-stained with 
saturated aqueous solution of uranyl acetate and lead 
citrate. Sections were finally analyzed using a JEM-1010 
transmission electron microscope (JEOL, Tokyo, Japan) 
equipped with a Mega-View-III digital camera and a 
Soft-Imaging-System (SIS, Münster, Germany) for the 
computerized acquisition of the images.
Stereology and quantitative morphometry
Parameters related to nerve regeneration (mean fiber 
density, total fiber number, fiber and axon diameter, 
myelin thickness and g-ratio) were estimated at electron 
microscopic level using a protocol previously described 
[40]. We randomly selected three nerve specimens of 
each group from animals with motor recovery detect-
able as evoked CMAP recorded from the tibialis anterior 
muscle. Briefly, one randomly selected ultra-thin sec-
tion was chosen and 20–25 fields were selected using a 
systematic random sampling protocol (magnification of 
4000×). Then, in each sampling field, a two-dimensional 
dissector procedure was adopted to count (and then 
measure) myelinated fibers [41]. The total cross-sectional 
area of the whole regenerated nerve was obtained on a 
semi-thin section (with 10× of magnification).
Evaluation of macrophage polarization on chitosan films
To get an insight into the mechanism by which chitosan 
films inserted into the CFeCNGs could support periph-
eral nerve regeneration, additional in  vitro experiments 
have been conducted. These experiments focused on the 
role of macrophages within the regeneration process.
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Material preparation
Sterile chitosan films (CF) with a DA of 5% were cut 
in squares of 2  ×  2  cm and fixed in cell crowns (Cell-
Crown™24,  Scaffdex®, Finland) for later insertion into 
24-well plates (Nunclon™ Delta Surface, Thermo Fischer 
Scientific, Denmark). First, the fixed CFs were washed 3 
times for 30  min at room temperature in sodium chlo-
ride (NaCl 0.9%, B. Braun Melsungen GmbH, Germany). 
Afterwards, the washing solution was replaced by mac-
rophage generation medium composed of RPMI 1640, 
supplemented with 2  mM  l-glutamine, 100  mg/ml 
penicillin/streptomycin, 12 mM Hepes, and 5% v/v FCS 
(PAN-Biotech; all other media components from Bio-
chrom, Berlin, Germany). CFs were soaked in the mac-
rophage generation medium for 72  h in the incubator 
(37 °C, 5%  CO2; Sanyo  CO2 Incubator, Ewald Innovation-
stechnik, Germany) before initial seeding of the cells.
In vitro differentiation of human monocyte derived 
macrophages
Residual blood samples from platelet (PLT) apheresis 
disposables used for routine PLT collection and of regu-
lar anonymous healthy donors served as source material 
for the isolation of human peripheral blood mononu-
clear cells (PBMCs). PBMCs were separated by density 
gradient centrifugation on lymphoprep (Pancoll, PAN-
Biotech, Aidenbach, Germany). To examine the influ-
ence of chitosan on the differentiation process of human 
macrophages, the PBMCs were plated with a seeding 
density of 1 × 106 cells pro well in a 24-well cell culture 
polystyrene plate (non-coated bottom of 24-well cell cul-
ture plate, regular well ground, WG, Nunclon™ Delta 
Surface) on plain well grounds or on the inserted soaked 
CFs in an appropriate amount of macrophage generation 
medium. To attach the monocytes, the cells were incu-
bated for 2  h at 5%  CO2 and 37  °C. The non-adherent 
cells were removed by vigorously washing the adherent 
cells three times with phosphate buffered saline (PBS, 
Merck KGaA, Germany) and 1 ml macrophage genera-
tion medium was added. The cells were incubated for 
4  days at 5%  CO2 and 37  °C without medium change. 
In one approach, the macrophages either attached on 
the well ground or on CFs were differentiated in mac-
rophage generation medium supplemented with mac-
rophage-colony stimulating factor (M-CSF) (10  ng/ml) 
(R&D, Wiesbaden, Germany), a cytokine which pro-
motes the M2 phenotype. At day 4, another 70% by vol-
ume of fresh medium was added. At day 7, the medium 
was completely changed.
Microscopic evaluation of cell morphology
Every 24 h, cell growth was examined using a phase con-
trast microscope (Olympus IX 70 microscope, Olympus, 
Germany) and changes in morphology were recorded 
using CellP software (Olympus, Germany).
Flow cytometric analysis of macrophage differentiation 
and cell surface markers
At day 2, 4 and 8 the differentiated macrophages were 
carefully scraped from the CFs or well ground of the cul-
ture plates and seeded (5 × 105 cells per well) into 96-well 
plates. Cells were washed with PBS. Subsequently the Fc 
receptors were blocked by incubation in a buffer contain-
ing 10 µg/ml heat-aggravated human immunoglobulin G 
(IgG) (Sigma, Deisenhofen, Germany). For extracellular 
staining the following antibodies were used: anti-CD163-
PE (BioLegend, San Diego, CA, USA), anti-CD206-PE, 
(BD Pharmingen, Heidelberg, Germany) and anti-CCR7-
FITC (R&D Systems) and the respective isotype controls 
to define the unspecific background staining. For intra-
cellular staining cells were fixed, permeabilized using 
the BD Cytofix/Cytoperm fixation/permeabilization kit 
(BD Bioscience, Heidelberg, Germany) and anti-CD68-
APC (BioLegend) or the respective isotype control was 
applied. Stained cells were washed three times and resus-
pended in PBS. Sample acquisition was performed by 
flow cytometry (FACS Calibur, Becton Dickinson, Hei-
delberg, Germany) and geometric mean fluorescence 
intensities (MFI) were calculated by CellQuest Pro soft-
ware (Becton Dickinson).
Statistics
Data obtained in the different studies were subjected to 
statistical analysis. For the short-term experiments (soft-
ware IBM SPSS Statistics, version 22) results are pre-
sented as median values [with 25th–75th percentiles] 
due to the non-normal distribution of data. The Kruskal-
Wallis test was used to determine any significant differ-
ence between the four groups, while the Mann–Whitney 
post hoc test was used to specifically identify differ-
ences between the four groups only if the Kruskal–Wal-
lis p-value was <0.05: hCNG-Ihealthy, CFeCNG-Ihealthy, 
hCNG-Idiabetic and CFeCNG-Idiabetic. Separate p-values 
from the Mann–Whitney post hoc test for healthy/dia-
betic rats and hCNG-I/CFeCNG-I were then combined 
to a single p-value by using the Fisher method for inde-
pendent samples based on the Chi square distribution 
[42, 43], courtesy by statistician Professor Jonas Björk, 
Lund University, Lund, Sweden [14]. Spearman rank cor-
relation test was used to evaluate the association between 
specific different parameters (expressed as rho-values 
and p-values). A p-value of less than 0.05 was considered 
significant.
For the long-term experiments two-way ANOVA 
(Analysis of Variance) followed by Tukey’s multiple 
comparison was used [GraphPad Prism for Windows in 
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version 6.05 (GraphPad Software, USA)]. The proportion 
of animals per group that displayed a predefined quali-
tative parameter (evocable CMAP or macroscopically 
visible tissue regeneration) was calculated as percentage 
(0–100%) and analyzed with the Chi square test to elu-
cidate differences between the hCNG-II and CFeCNG-II 
group. As level of significance, the p-value was set at 
<0.05.
Statistical analysis of the results obtained in vitro was 
performed using two-way ANOVA (Analysis of Variance) 
followed by Tukey’s multiple comparison [GraphPad 
Prism for Windows in version 6.05 (GraphPad Software, 
USA)].
Abbreviations
ATF‑3: activating transcription factor 3; BSA: bovine serum albumin; CCR7: 
chemokine receptor antigen; CD68: macrophage differentiation antigen; 
CD163: scavenger receptor; CD206: alpha‑mannose receptor; CF: chitosan film; 
CFeCNG: chitosan film enhanced chitosan nerve guide; ChAT: choline acetyl‑
transferase; CMAP: compound muscle action potential; DAPI: 4′,6′‑diamidino‑
2‑phenylindole; DRG: dorsal root ganglion; FACS: flow cytometry; FCS: fetal 
calf serum; hCNG: hollow chitosan nerve guide; HSP‑27: Heat Shock Protein 
Additional files
Additional file 1: Figure S1. Suture technique to prevent spontaneous 
recovery of free nerve ends. (A) Photograph of one nerve end sutured 
in the described loop‑like shape. The scale paper in top of the picture 
indicates the dimensions of the sutured nerve end in mm. (B) Stepwise 
illustration of the suture technique. The first puncture was made through 
the epineurium around 2 mm next to the nerve end exiting at the medial 
transection level. The second puncture was entering only the epineurium 
of the nerve and exiting parallel to the transection site. Finally the suture 
was tied up to generate the loop‑like shape of the nerve end.
Additional file 2: Figure S2. Detection of ATF‑3 or cleaved caspase‑3 
stained Schwann cells in distal nerve segments after reconstruction. 
Photomicrographs present distal nerve segments at 56 days after 45 days 
delayed reconstruction double‑stained for ATF‑3 (A‑D, in green) or cleaved 
caspase‑3 (E‑H, in green) with S‑100 (A‑H, in red). The inserts in A and E 
show a detail of a double‑stained Schwann cell (S‑100‑immunopositive, 
red) with enclosed ATF‑3 (green) or cleaved caspase‑3 (green), respec‑
tively. Abbreviations: hCNG‑Ihealthy = hollow chitosan nerve guide from 
healthy rats; CFeCNG‑Ihealthy = chitosan film enhanced chitosan nerve 
guide from healthy rats; hCNG‑Idiabetic = hollow chitosan nerve guide from 
diabetic GK rats; CFeCNG‑Idiabetic = chitosan film enhanced chitosan nerve 
guide from diabetic rats. For detailed results of the quantification see 
Table 2. Scale bars display 100 µm in all images.
Additional file 3: Figure S3. Quantitative analysis of motor recovery 
over 150 days post delayed reconstruction. As depicted by dot plots, 
the recovery of the evoked compound action muscle potential (CMAP) 
amplitude ratios (A) and the nerve conduction velocity ratios (B) displayed 
no significant quantitative difference between the two groups over the 
150 day observation time after delayed nerve reconstruction. The lower 
limb muscle weight ratio (C) as determined at the endpoint of the study 
(150 days) did also not reveal any significant quantitative difference 
between the groups. Error bars indicate median ± range.
Additional file 4: Figure S4. Representative high resolution images of 
ultrathin cross‑sections. Photomicrographs show distal nerve segments 
of animals without an evocable CMAP, hCNG‑II (A) and CFeCNG‑II (B), in 
contrast to samples of animals with evocable CMAPs, hCNG‑II (C) and 
CFeCNG‑II (D), 150 days after reconstruction. Scale bar displays 5 µm for 
all pictures.
27; GK: Goto‑Kakizaki; M‑CSF: macrophage‑colony stimulating factor; MFI: 
geometric mean fluorescence intensities; MHH: Medizinische Hochschule 
Hannover, i.e. Hannover Medical School; MIA: multiple image alignments; 
NA: not applicable; NF200: neurofilament 200; KW: Kruskal–Wallis; PBMC: 
human peripheral blood mononuclear cell; PBS: phosphate buffered saline; PL: 
plantaris interosseous muscle; PLT: residual blood samples from platelet; SND: 
distal nerve segment; TA: tibialis anterior muscle; TFO: too few observations to 
apply statistics; ULUND: University of Lund; UNITO: University of Turin; WG: well 
ground, i.e. regular cell culture surfaces.
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